Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy
Abstract
Progressive pulmonary fibrosis (PPF) is the leading cause of death in systemic sclerosis (SSc). This study aimed to develop a clinical prediction nomogram using clinical and biological data to assess risk of PPF among patients receiving treatment of SSc‐related interstitial lung disease (SSc‐ILD).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 17, 2023
- Source ID
- 10.1002/acr2.11598
Entities
People
- Donald P. Tashkin
- Elizabeth R Volkmann
- Holly Wilhalme
- Hyun Kim
- Jonathan Goldin
- Masataka Kuwana
- Michael D. Roth
- Shervin Assassi
Organizations
- National Heart, Lung, and Blood Institute
- Nippon Medical School
- United States Department of Defense
- University of California, Los Angeles
- University of Texas Health Science Center at Houston